IDIBELL researchers identify a new leukodystrophy in children and its potential cure

The Neurometabolic Diseases research team at IDIBELL and CIBERER, led by Aurora Pujol, has uncovered a novel disease of children affecting the brain white matter — the myelin sheath –, leading to severe incapacity and death in some cases. These defects were corrected by a treatment with fingolimod, a drug in use for multiple sclerosis which interferes with this pathway.
Go to Source